more frequently faced complications were foot ulcers (DFUs). 3, 4 Nearly 15% of diabetic patients will suffer from DFU in their life span. 5, 6 Proper wound caring is very important for DFU otherwise they are the greater source for morbidness, gangrene, amputation. Improper management of DFUs may leads to mortality in some cases. 7, 8 DFUs may cause notable physical, psychological stress and also affects the productivity which may leads to financial problems and also lowers the patients quality of life. 9 Still there is a uncertainty about basic pathophysiological factors leading to DFUs, the triad of neuropathy, ischaemia and infections are treated as the routine and most important cause. 10 Low angiogenic response and deficiency of growth factors may be responsible for delayed healing of wounds in DFUs. 11 In recent days so many adjuvant therapies which have been tried to stimulate healing process are in use which includes ultrasound, laser therapy and other forms of photo bio modulation, electrical stimulation, hyperbaric oxygen and vacuum-assisted closure. 12 Although laser therapy has been investigated since the 1990s for possible improvements in the healing of wounds, reproducible results not available in literature may stops its wide range of usage in wound healing. 13, 14 Most of the study findings stated that laser therapy, or low-level laser therapy (LLLT), modulates the expression of inflammatory mediators and leads to a reduction in edema, leukocyte influx, and oxidative stress. 15 Further, LLLT has been shown to stimulate neo vascularization and collagen remodeling 16 to heal the wounds in faster way. Few of the studies shows that 660nm wave length shows more viability than longer wavelength. 17 A study supports that the better results are found with a dose of 3J/cm 2 by changing doses of 632.8nm He-Ne laser irradiation. 18 LLLT was invented since 1990s to induce wound healing process of different ulcers but its implementation in India is still at budding stage because of less research in this field. Even though many studies have listed in literature on the efficacy of low level laser therapy to treat DFUs, but in Indian scenario there are minimum number of studies. 14, [19] [20] [21] [22] [23] [24] There is a need in India to accelerate the research on the viability of low level laser therapy to avoid the backlogging in its implementation. The aim of this study was to study the role of LLLT on diabetic ulcers, i.e. reduction in size of the ulcer, faster wound healing, control of infection, cost effectiveness and if secondary procedures like split skin grafting can be avoided.
METHODS
The current study was randomized open labelled control study, with randomized two treatment groups and total sample size of 100.
• Group A: Intervention group (who received laser therapy in addition to standard management) • Group B: Control group (standard treatment group) Study setting: The study was conducted in the department of general surgery, Chettinad hospital and research institute, which is a tertiary care teaching hospital Study duration: The recruitment of the participants was conducted over a period of 1 year from june 2016 to july 2017. All the subjects were followed up after 15 days of administering the intervention
Inclusion criteria
Diabetic foot ulcer patients aged between 30 to 80. Good glycemic control patients with fasting blood sugar (FBS) levels measured on two occasions 24 h apart between 90 and 200mg/dl with glycosylated haemoglobin (HbA1c) levels between 6% and 9% will be included. Wound size below 10cm and diabetic ulcers from grade 1 to 2.
Exclusion criteria
• Presence of osteomyelitis.
• Those with clinical signs of ischemia and ABI less than 0.9.
• Patients associated with critical illness who needs intensive care.
Study procedure
After obtaining the informed written consent, relevant demographic and clinical parameters were documented in a structure proforma. The exact dimensions of the ulcer were noted, and each ulcer was graded using the warner grading system as follows.
Wagner grading system
• Grade 1: Superficial diabetic ulcer • Grade 2: Ulcer extension, involves ligament, tendon, joint capsule or fascia • Grade 3: Deep ulcer with abscess or osteomyelitis • Grade 4: Gangrene to portion of forefoot • Grade 5: Extensive gangrene of foot All patients were admitted in the surgical ward and evaluated thoroughly. Both acute as well as chronic ulcers were included in the study. The size of the ulcer was measured with ruler. Objective assessment of vascularity was done by careful palpation of peripheral pulses and calculation of Ankle brachial index. Colour Doppler imaging of the arterial circulation of lower limbs was performed in patients with feeble or absent and those with signs of ischemia and cases with <0.9 ABI were excluded from the study. Plain radiographs were used to find the presence of osteomyelitis and those cases were excluded from the study.
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Administration of intervention
All patients in both the groups received the required, conventional treatments of diabetic wound care, including dressing, antibiotics, controlling diabetes, cholesterol, and blood pressure along with aggressive drug treatment and wound debridement when needed, before, after and during the laser therapy procedure.
Patients in the study group received treatment with LLLT. Ulcer bed with edge was irradiated locally with red light (660nm). Ulcer size and its depth were used as basis to calculate the duration of exposure to deliver 4-8J/cm 2 for 20 minutes, for 15 days on daily basis. Conventional dressing was preferred for covering after irradiation and controls were treated with conventional therapy alone which includes dressings with betadine or wet with saline, course of antibiotic treatment and slough removed whenever needed. At baseline and day 15, size of the ulcer was measured with a ruler. Wound swab for culture and sensitivity was taken both in control and study group on day 0 and day 15. Grade of ulcer assessed before starting the treatment and on day 15. Systemic antibiotics were suggested to use with the help of culture sensitivity reports. Good glycemic control was maintained by having Insulin/oral hypoglycaemic agents (OHA) on the advice of physician.
Informed consent was obtained from each study participant, after explaining the risks and benefits involved in the study and voluntary nature of participation, in a language participant can understand.
Statistical analysis
Area of the ulcer was considered as primary outcome variable. The mode of treatment standard vs Intervention) was considered as primary explanatory variable. Various demographic, diabetes disease related, and treatment related parameters were considered as other potential confounding variables. Descriptive analysis was carried out by mean and standard deviation for quantitative variables, frequency and proportion for categorical variables. Data was also represented using appropriate diagrams like bar diagram, pie diagram and box plots.
Both the study groups were compared at the baseline with respect to all potential confounders. The area of the ulcer was compared between the two groups, using independent sample t-test. The mean differences along with their 95% CI were presented. Association between quantitative explanatory and outcome variables was assessed by calculating person correlation coefficient and the data was represented in a scatter diagram. P value <0.05 was considered statistically significant. IBM SPSS version 22 was used for statistical analysis.
RESULTS
Among the study participants, 50 (50.00%) were Cases and 50 (50.00%) were Controls. The mean Age was 52.1±8.940 in cases and mean Age was 52.48±11.57 in controls. The mean difference across the group is (-0.38) and it is statistically not significant (p value 0.855). The proportion of male in cases was 26 (52%) and female was 24 (48%) whereas the proportion of male in controls was 31 (62%) and female was 19 (38%). The association of gender with the study groups was statistically not significant (p value 0.31). In study group B, among the 50 subjects 26 were grade 2 ulcers and 24 were grade 1 ulcers on day 1. At the end of 15 days, number of grade2 ulcers that remained in grade 2 was 23 (88.46%) and 3 ulcers (11.53%) improved to grade 1.
Among 24 grade1 ulcers all remained in grade1 and no (0.00%) ulcers healed completely at the end of 15 days (Table 3) . In group B, 34 subjects had bacterial growth on day-1 and the remaining 16 had no bacterial growth.
Out of the 34 with bacterial growth, 29 (85.25%) still had growth at the end of 15 days and 5 (14.71%) had no growth. Among 16 people who had no growth, 3 (18.75%) cases developed new bacterial growth (Table  5 ). 
DISCUSSION
Diabetic foot ulcers are the most common complications of diabetes mellitus and conventional wound healing therapies are not that much effective for DFUs and if proper treatment was not given to the DFUs they may herald severe complications. Wound healing can be initiated by treating with a beam of electromagnetic radiations or laser. In the existing literature, few studies are available in this area. 14, [19] [20] [21] [22] [23] [24] The current study was aimed to assess the adequacy of a treatment modality with LLLT for diabetic foot ulcers.
Ulcer grade
In the current study, among 50 subjects of a group A study participants 29 were grade-2 ulcers and remaining 21 were grade 1 ulcers at baseline. 26 21 open wounds were treated with low level laser therapy and at the end of 9 weeks of treatment, the major proportion of wounds (61.9%) improved significantly. 42.8% were closed completely, minimum improvement was found in 14.3% cases and no change was reported in 23.8% wounds.
Bacterial growth status
In present study among group A participants, at base line 31 subjects had bacterial growth and remaining 19 had no bacterial growth. At the end of 15 days in 31 cases with bacterial growth, growth was absent in 67.74% cases and in 32.25% cases growth still remained. In 19 cases with no growth on day-1, no new growth developed even after 15 days. Among group-B study participants, at base line 34 subjects were having bacterial growth and the remaining 16 had no growth. On day 15 in 34 subjects with bacterial growth 85.25% of cases still showrd growth and 14.7% had no growth. In 16 cases with no growth at day-1, 81.25% of cases had no growth but in 3 subject's growths was observed after 15 days of treatment. A study conducted by Tubachi P et al, findings were also in agreement with current study findings. 27 He studied 60 patients of diabetic foot ulcer and positive for culture. After 10 days of treatment, among treatment group subjects 66.66% were showing culture positive results and 33.3% were with negative culture reports. In controls (N=30) 80% of subjects had positive cultures and in 20% of subject s were culture negative.
Ulcer size
In present study reported that the mean area of the ulcer was 13 14 Mean reduction was minimal in controls when compared to cases. Study of Hopkins et al agreed with the current study findings and shows that after conducting follow up tests for days 6,8 and 10 days observed that wound size was reduced in laser group than the sham group for both treated as well as untreated wounds and the difference in size reduction between the two groups was statistically significant. 21 Gupta AK et al, have reported that there was a great reduction in ulcer area of LEPT group than the placebo group (193.0mm 2 Vs 14.7mm
2 ) with statistically significant difference in ulcer area between two study groups (P=0.0002).
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CONCLUSION
In conclusion, Laser therapy is painless, cost effective procedure which induces faster granulation, wound contraction and re-epithelialization, thus accelerates complete wound healing hence avoiding secondary procedures like split skin grafting. Control of infection was also better compared to control group.
